Bridge Bio to Present Outcomes Data from ATTRibute-CM Study at 2024 AHA Scientific Sessions
Analyzing Prognostic Factors, Survival Based on Histological Type for Endometrial Cancer Patients Treated With Hysterectomy
FDA Approves Neoadjuvant, Adjuvant Nivolumab for Resectable NSCLC